In-Vitro Diagnostic Substance Manufacturing
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices. Cross-References.Show more
NAICS 325413 – In-Vitro Diagnostic Substance Manufacturing encompasses the production of reagents, kits, calibrators, controls, and other chemical or biological substances used in laboratory-based diagnostic testing. These products enable the detection, measurement, or monitoring of physiological conditions, infectious agents, biomarkers, and genetic markers in clinical specimens such as blood, urine, and tissue.
Contract Opportunities
Active solicitations and awarded contracts classified under NAICS 325413 — In-Vitro Diagnostic Substance Manufacturing.
Frequently Asked Questions
Recently Posted in In-Vitro Diagnostic Substance Manufacturing
Win Contracts in In-Vitro Diagnostic Substance Manufacturing
Get AI-powered intelligence on NAICS 325413 procurement
Real-time contract opportunities for NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing)
AI-powered matching based on your business capabilities and past performance
Competitive analysis of contractors winning awards in this industry
Automated alerts when new opportunities are posted
Join 650+ contractors already using CLEATUS
